Extramural Funding

Print

The following is a list of active extramural funding opportunities, provided as a courtesy to UCLA Jonsson Comprehensive Cancer Center members. To be included on this list, funding must be unlimited or not administered directly by the JCCC.

Listings are generally updated as a batch on a monthly basis. Entries are ordered by posting date, with most recent postings first. Funding opportunities are removed from this list once their final application due date has passed.

**IMPORTANT** The 21st Century Cures Act was signed into law in December 2016, and authorizes $1.8 billion over seven years to fund the Beau Biden Cancer Moonshot Initiative. The National Cancer Institute has released numerous funding opportunity announcements, and additional funding initiatives are anticipated. You are encouraged to visit their website for a complete and current list of funding opportunities that may be available to you.

Posted July 18, 2018

Parker Institute for Cancer Immunotherapy Center Innovative Science in Cancer Immunotherapy Program

Application Due Date(s): Friday, August 31, 2018 by 3:00 p.m. PST

How to Apply: Materials must be submitted electronically via email

Description: The Parker Institute for Cancer Immunotherapy (PICI) Center at UCLA is requesting applications from UCLA faculty proposing research leading to innovative science in cancer immunotherapy that will enable collaboration and accelerate ambitious research. The program provides two years of support. The PICI Center at UCLA does not guarantee funding of any applications during a particular award cycle.

Areas of interest include: engineered T cells for adoptive cell transfer therapy; response and resistance to immune checkpoint blockade therapies; discovery of specific tumor antigens; and analysis and drugging the tumor microenvironment. Eligibility requirements are that you must be a member of the UCLA faculty, and only one proposal per primary investigator. PI’s who receive funding will be considered a Project Member of the PICI Center at UCLA, subject to the execution of a Project Agreement and Participation Agreement. Awards will be for two years, contingent on adequate research progress. Additional years of funding require competitive review. Maximum total budget of $250,000 per year.

Application materials that must be submitted include: 1.) one-page concise description of the research proposal and goals, 2.) one-page estimated total budget and general breakdown of projected expenses, 3.) NIH biosketch for PI only (five-page maximum). Submitted documents are assessed and rated according to scientific merit by intra- and extra-mural peer reviewers appointed by the Center Director. Following committee review and scientific priority ranking of all applications, recommendations for funding will be developed by the Director’s Administrative Review Committee in accordance with the available research funds. The review process is confidential and applicants will not receive comments or scores.

Posted July 9, 2018

NCI Community Oncology Research Program (NCORP) Research Bases

Application Due Date(s): Internal Proposal Deadline 07/17/2018 / Letter of Intent Deadline 07/31/2018 / Full Proposal due to agency 08/31/2018

How to Apply: More information can be found at the LSO portal page.

Description: This Funding Opportunity Announcement (FOA) solicits applications from institutions/organizations to participate as "Research Bases" for the National Cancer Institute (NCI)-supported Community Oncology Research Program (NCORP). NCORP is a community-based research network.


NIH Director's Early Independence Award

Application Due Date(s): Internal Proposal Deadline 07/31/2018 / Letter of Intent Deadline 08/27/2018 / Full Proposal due to agency 09/27/2018

How to Apply: More information can be found at the LSO portal page.

Description: The NIH Director's Early Independence Award provides an opportunity for exceptional junior scientists to accelerate their entry into an independent research career by forgoing the traditional post-doctoral training period. Though most newly graduated doctoral-level researchers would benefit from post-doctoral training, a small number of outstanding junior investigators would benefit from skipping such training and launching essentially directly into an independent research career. For those select junior investigators who already have established a record of scientific innovation and research productivity and who have demonstrated unusual scientific vision and maturity, typical post-doctoral training would unnecessarily delay their entry into independent research.


Robert L. Fine Cancer Research Foundation

Application Due Date(s): August 31, 2018

How to Apply: More information can be found via their website.

Description: The Robert L. Fine Cancer Research Foundation will distribute one to two awards per year to outstanding young scientists dedicated to basic and translational pancreatic cancer research. The grant is intended to support research projects that can be carried out in a short period of time with limited resources. The topic of the requested grant applications will be for innovative translational pancreatic cancer research that focuses on bench to bedside advances. The grant mechanism supports different types of basic and translational projects including pilot and feasibility studies, self-contained research projects, development of new research methodology and development of new research technology.

This grant does not support solely clinical research. Grant Mechanism Monetary awards will be granted to research projects written in response to a once yearly Funding Opportunity Announcement (FOA). The grant amount will be $250,000 to cover direct costs only. The length of the grant will be for two years payable in yearly installments. Pre-award costs are allowable, up to 30 days prior to the grant initiation date; however the incurrence of pre-award costs imposes no obligation on the foundation to grant the award.

Posted June 8, 2018

2018 Lori Monroe Scholarships in Translational Lung Cancer Research

Application Due Date(s): Wednesday, August 1

How to Apply: Applications are due via the IASLCF’s online portal.

Description: The objective of this award is to support research that improves the care of individuals with lung cancers and to reduce the burden of these diseases. Examples include studies: (1) designed to define the molecular bases of lung cancer risk assessment; (2) to improve molecular diagnostic studies designed to detect the lung cancer early and guide curative-intent therapy; (3) predictive features guiding the use of targeted or immune oncology therapy to reduce recurrence after standard curative-intent strategies in early stage disease; (4) or to improve the outcomes or cure patients with metastatic lung cancer. Studies designed to facilitate care by minimizing treatment side effects or illuminating the causes of nonsmoking related lung cancer are encouraged, as well.

The maximum funding for the award will be in the amount of $200,000. The award amount will be $100,000 per year for up to two years. The second year of support is based on demonstrating satisfactory progress as determined by LCFA/IASLCF as well as the availability of funding from LCFA/IASLCF. No more than 25 percent of the requested budget may be used for an awardee’s salary and/or fringe benefits and no award budget may be used to fund the purchase of permanent equipment. No indirect costs are provided. Any unused award funds at the conclusion of the study period will be returned to the study sponsor.

Posted May 6, 2018

Defense Health Program Concept Award

Application Due Date(s): Letter of Intent due July 26, 2018.

How to Apply: For more information, visit their website.

Description: Supports new ideas in the early stages of development representing innovative, high-risk/high-gain research. Emphasis on innovation and impact. New Investigators: Supports applicants early in their faculty appointments or in the process of developing independent research careers. Clinical trials not allowed. Preliminary data required, but may be from outside of lung cancer. Military relevance strongly encouraged. Maximum funding of $350,000 in direct costs (plus indirect costs). Period of performance should not exceed two years.


Defense Health Program Idea Development Award

Application Due Date(s): Preproposal due June 26, 2018.

How to Apply: For more information, visit their website.

Description: Supports new ideas in the early stages of development representing innovative, high-risk/high-gain research. Emphasis on innovation and impact. Supports applicants early in their faculty appointments or in the process of developing independent research careers. Clinical trials not allowed. Preliminary data required, but may be from outside of lung cancer. Military relevance strongly encouraged.

Maximum funding of $350,000 in direct costs (plus indirect costs). Period of performance should not exceed two years.


Defense Health Program Investigator-Initiated Translational Research Award

Application Due Date(s): Preproposal due June 26, 2018.

How to Apply: For more information, visit their website.

Description: Independent investigators at or above the level of Assistant Professor (or equivalent). Supports translational research that will develop promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. Intended to fund a broad range of translational studies. Clinical trials not allowed. Preliminary Date required, but may be from outside of lung cancer. Military relevance strongly encouraged.

Maximum funding of $400,000 in direct costs (plus indirect costs). Period of performance should not exceed two years.


Defense Health Program Translational Research Partnership Award

Application Due Date(s): Preproposal due June 26, 2018.

How to Apply: For more information, visit their website.

Description: Investigators at or above the level of Assistant Professor (or equivalent). Supports partnerships between clinicians and laboratory scientists that accelerate ideas in lung cancer into clinical applications. One partner is strongly encouraged to be from a Department of Defense military treatment facility or laboratory, or Veterans Affairs medical center or research laboratory. Non-Traditional Partnerships are encouraged. Clinical trials are allowed. Preliminary data required, but may be from outside of lung cancer.

Maximum combined funding of $900,000 in direct costs (plus indirect costs). Maximum period of performance is three years. Military relevance strongly encouraged.


Defense Health Program Career Development Award

Application Due Date(s): Letter of Intent due August 28, 2018

How to Apply: For more information, visit their website

Description: Supports independent, early-career investigators to conduct impactful research with the mentorship of an experienced cancer researcher. Must address at least one of the FY18 PRCRP Topic Areas, and at least one of the FY18 PRCRP Military Relevance Focus Areas. Preliminary data are not required, and clinical trials are not allowed.

Maximum funding for the entire period of performance is $360,000 in direct costs (plus indirect costs). Maximum period of performance is three years

Posted April 11, 2018

Leukemia and Lymphoma Society Career Development Grant

Application Due Date(s): October 2, 2018

How to Apply: For more information, visit their website

Description: Scholar Award: $110,000 per year for five years / Scholar in Clinical Research Award: $125,000 per year for five years / Special Fellow Award: $67,000 per year for two or three years / Fellow Award: $60,000 per year for three years.


Cancer Research Institute Clinic & Laboratory Integration Program (CLIP)

Application Due Date(s): November 1, 2018

How to Apply: For more information, visit their website

Description: The development of new and effective cancer treatment requires the translation of basic laboratory discoveries into novel therapies that can be tested in patients. This area of translational research—where laboratory findings move into clinical testing and where questions from clinical studies are brought back into the lab—is critical to bringing new and better immunotherapies to patients.

The Cancer Research Institute established CLIP to support investigators who are studying critical topics at the intersection of laboratory and clinical research. CLIP grants provide up to $200,000 over a two-year period.


Damon Runyon Cancer Research Foundation Physician-Scientist Training Award

Application Due Date(s): December 3, 2018

How to Apply: For more information, visit their website

Description: Physician-scientists who are both clinically trained and expert researchers are essential to the successful translation of scientific discovery into more effective patient therapies. They have the unique capacity to blend their insights from treating patients and working in the laboratory in a way that enables and accelerates medical advances. However, the pipeline of physician-scientists is dwindling. The decline in this vital cadre of cancer researchers is occurring at a time when cancer research holds the greatest promise of improving survival and quality of life among cancer patients. A growing shortage of physician-scientists means that major laboratory research discoveries will progress to patient application ever more slowly. If the shortage continues unabated, some may not reach patient application at all, thus presenting a crisis in cancer research.